Clinical Response to Vedolizumab in Ulcerative Colitis Patients Is Associated with Changes in Integrin Expression Profiles
- Location
-
Deutsche Nationalbibliothek Frankfurt am Main
- Extent
-
Online-Ressource
- Language
-
Englisch
- Bibliographic citation
-
In: Frontiers in Immunology 8 (2017).
- Keyword
-
-
- Event
-
Veröffentlichung
- (where)
-
Erlangen
- (who)
-
Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
- (when)
-
2017
- Creator
-
Fuchs, Friederike
Schillinger, Daniela
Atreya, Raja
Hirschmann, Simon
Fischer, Sarah
Neufert, Clemens
Atreya, Imke
Neurath, Markus F.
Zundler, Sebastian
- URN
-
urn:nbn:de:bvb:29-opus4-94537
- Rights
-
Der Zugriff auf das Objekt ist unbeschränkt möglich.
- Last update
-
14.08.2025, 10:46 AM CEST
Data provider
This object is provided by:
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Deutsche Nationalbibliothek. If you have any questions about the object, please contact the data provider.
Associated
- Fuchs, Friederike
- Schillinger, Daniela
- Atreya, Raja
- Hirschmann, Simon
- Fischer, Sarah
- Neufert, Clemens
- Atreya, Imke
- Neurath, Markus F.
- Zundler, Sebastian
- Friedrich-Alexander-Universität Erlangen-Nürnberg (FAU)
Time of origin
- 2017
Other Objects (12)
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Role of the IL23/IL17 Pathway in Crohn’s Disease
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Role of the IL23/IL17 Pathway in Crohn’s Disease
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets
Oligonucleotides—A Novel Promising Therapeutic Option for IBD
Predicting Therapeutic Response by in vivo Molecular Imaging in Inflammatory Bowel Diseases
Endoscopic Therapy in Inflammatory Bowel Diseases
Personalizing Treatment in IBD: Hype or Reality in 2020? Can We Predict Response to Anti-TNF?
Role of the IL23/IL17 Pathway in Crohn’s Disease
Effects of Anti-Integrin Treatment With Vedolizumab on Immune Pathways and Cytokines in Inflammatory Bowel Diseases
Quantitative contrast-enhanced ultrasound for monitoring vedolizumab therapy in inflammatory bowel disease patients: a pilot study
Endoscopy as a Diagnostic Tool for Personalized Therapy in IBD: Prediction of Response to Biological Therapy
Vedolizumab blocks α4β7 integrin-mediated T cell adhesion to MAdCAM-1 in microscopic colitis
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Clinical experiences and predictors of success of treatment with vedolizumab in IBD patients: a cohort study
Limited Dose-Dependent Effects of Vedolizumab on Various Leukocyte Subsets